A phenotypic change of small intestinal epithelium to colonocytes in small intestinal adenomas and adenocarcinomas.
OBJECTIVE
Using a novel monoclonal antibody (mAb Das-1) that specifically reacts with colon epithelium, we examined if there is a phenotypic change of small intestinal enterocytes toward colonocytes in small intestinal neoplastic tissue.


METHODS
Tissue sections of the small intestine consisting of adenomas (n = 20, five with histories of familial polyposis), adenocarcinomas (eight primary and one metastatic from colon). carcinoids (n = 2), and hyperplastic polyps (n = 3) were examined by a sensitive immunoperoxidase assay using mAb Das-1 (IgM isotype). Normal jejunal (n = 10) and colonic (n = 10) biopsy specimens were also included as additional controls.


RESULTS
mAb Das-1 reacted with normal colonic epithelium but not with jejunal mucosa. However, mAb Das-1 reacted strongly with each of the five adenomas (100%) from patients with histories of familial polyposis, but only five of 15 (33%) of the adenomas from nonfamilial polyposis patients, and each of the eight (100%) adenocarcinomas of the small intestine (p < 0.001). The reactivity with the adenomas from nonfamilial polyposis patients was very focal, whereas in the adenomas with familial polyposis the reactivity was more extensive. Each of the eight carcinomas reacted strongly with mAb Das-1. Adjacent normal small intestinal mucosa did not react. Hyperplastic polyps and the carcinoids did not react with mAb Das-1.


CONCLUSIONS
These data demonstrate a phenotypic change in small intestinal epithelium toward the colonic phenotype, particularly in familial polyposis and in adenocarcinomas. mAb Das-1 may be clinically useful in identifying small intestinal adenomas with "high risk" for malignancy, such as in familial polyposis.
Onuma
E K
EK
Department of Medicine, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey 08903, USA.
Amenta
P S
PS
Jukkola
A F
AF
Mohan
V
V
Borra
S
S
Das
K M
KM
D000230:Adenocarcinoma / Q000276:immunology / Q000378:metabolism*; D000236:Adenoma / Q000276:immunology / Q000378:metabolism*; D011125:Adenomatous Polyposis Coli / Q000276:immunology / Q000378:metabolism; D000368:Aged; D000911:Antibodies, Monoclonal / Q000378:metabolism; D014408:Biomarkers, Tumor / Q000378:metabolism*; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D007413:Intestinal Mucosa / Q000378:metabolism; D007414:Intestinal Neoplasms / Q000276:immunology / Q000378:metabolism*; D007421:Intestine, Small / Q000378:metabolism*; D008297:Male; D010641:Phenotype; D011230:Precancerous Conditions / Q000378:metabolism*
D000911:Antibodies, Monoclonal; D014408:Biomarkers, Tumor